Schedule 13D ownership disclosure

ADVERUM BIOTECHNOLOGIES INC

Common Stock, par value $0.0001 per share · CUSIP: 00773U108

Event date: 2025-11-10

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BML Investment Partners, L.P.Reported CIK 0001373604

    Shares: 3,057,526 · Class: 14.6%

  • Leonard Braden MichaelReported CIK 0001373603

    Shares: 3,249,326 · Class: 15.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001373604-25-000116
Form type
SCHEDULE 13D/A
Filer
Adverum Biotechnologies, Inc.
CIK
CIK 1501756
Filed
Nov 10, 2025
Reporting period
Nov 10, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub